Something you have failed to acknowledge since you have been posting on the SPL forum is that Starpharma is a biotech .... one negative announcement (eg. DEP Doc phase 2 trial fails) and the share price would tank ... one positive announcement (eg. DEP License agreement with top 5 pharma or global pharma distribution deal for Viraleze) and the price would surge ....
.... there are no leaks with Starpharma as you seem to continually suggest is happening and the $35 million Agrochemicals deal in June 2017 is a classic example of that ... check out the share price trading in the lead up to that particular announcement .... it is easy to see why many have decided to put you on ignore - just sayin'
SPL Price at posting:
$1.61 Sentiment: Hold Disclosure: Held
